Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sagar R. Bhimani"'
Publikováno v:
Apollo Medicine.
Publikováno v:
European Journal of Clinical Medicine. 2:8-10
Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit SARS-CoV-2. In absence of any effective treatment for SARS-CoV-2 infection (COVID-19), Remdesivir has been tried for a compassionate use in severe COVID-19. Remdesivir has shown
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 11:132
Background: Adverse cutaneous drug reactions pose diagnostic difficulties due to a varied clinical manifestations and broad categories of causative agents. Fixed drug eruptions (FDE) are one of them. Present study aims i) to record various clinical f
Autor:
Pratik R. Patel, Supriya D. Malhotra, Parth Gupta, Sagar R. Bhimani, Ankit R. Mistry, Kamlesh P. Patel
Publikováno v:
International Journal Of Community Medicine And Public Health. 8:4518
Background: Coronavirus disease 2019 (COVID-19) has caused significant distress. Apart from evident physical symptoms in infected cases, it has caused serious damage to public mental health. The present study was carried out to assess disease burden,
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 10:851
SARS-CoV-2, the virus that causes coronavirus disease 19 (COVID-19), has spread rapidly around the world. Researchers have been working round the clock to develop effective vaccines, which people started receiving in December 2020. Therefore, careful